Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Lortalamine
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Routes of administration |
Oral |
ATC code |
|
Pharmacokinetic data | |
Elimination half-life | 5 hours |
Excretion | Renal (98%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H17ClN2O2 |
Molar mass | 292.76 g·mol−1 |
3D model (JSmol) | |
|
Lortalamine (LM-1404) is an antidepressant which was synthesized in the early 1980s. It acts as a potent and highly selective norepinephrine reuptake inhibitor. Lortalamine was under development for clinical use but was shelved, likely due to the finding that it produced ocular toxicity in animals. It has been used to label the norepinephrine transporter in positron emission tomography studies.
See also
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
DAT (DRIs) |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NET (NRIs) |
|
||||||||||||||
SERT (SRIs) |
|
||||||||||||||
VMATs | |||||||||||||||
Others |
|
||||||||||||||